
|Videos|April 14, 2017
New Parkinson Disease Treatment
Author(s)Bobby Lazzara, MD
Patients with Parkinson disease experiencing “off” episodes on levodopa/carbidopa now have another treatment option.
Advertisement
There is now another option for patients with Parkinson disease. The
In patients experiencing “off” episodes, safinamide has been shown in two clinical trials to be efficacious in reducing involuntary movement and improving motor function scores.
The most common side effects are falls, nausea, insomnia, and dyskinesia.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Roche Unveils PrevenTRON, a Phase 3 Prevention Trial of Trontinemab in Cognitively Unimpaired Individuals at High Risk of Alzheimer Decline
2
Alzheimer's Association Launches PROTECT-Cog Combination Prevention Trial
3
Sanofi's Oral TREM2 Agonist SAR448851 Advances to Phase 2 TREMHANCE Trial in Early Alzheimer Disease
4
Highlighting Gaps in Testing and Diagnosis for Fragile X Syndrome: Craig A. Erickson, MD
5


















